Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect
Identifieur interne : 000902 ( Main/Exploration ); précédent : 000901; suivant : 000903Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect
Auteurs : Ko Sato [Japon] ; Oshi Watanabe [Japon] ; Suguru Ohmiya [Japon] ; Fumiko Chiba [Japon] ; Masahiro Hayashi [Japon] ; Tamio Suzuki [Japon] ; Kazuyoshi Kawakami [Japon] ; Hidekazu Nishimura [Japon]Source :
- Microbiology and Immunology [ 0385-5600 ] ; 2016-11.
Abstract
Isolation of human parainfluenza virus (HPIV) serotypes 1 and 3 from clinical specimens is not very efficient because of the lack of a cell culture system capable of inducing CPE. In this study, the utility of a melanoma cell line, MNT‐1, that allows HPIV growth and displays CPE was demonstrated. In particularly, the efficiency of isolating HPIV1 and HPIV3 using MNT‐1 was greater than for cell lines conventionally used for HPIV isolation. Our demonstrated efficacy of HPIV1 and HPIV3 isolation with apparent CPE using the MNT‐1 cell culture system has the potential to improve virus isolation from clinical specimens.
Url:
DOI: 10.1111/1348-0421.12446
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000394
- to stream Istex, to step Curation: 000374
- to stream Istex, to step Checkpoint: 000007
- to stream Main, to step Merge: 000904
- to stream Main, to step Curation: 000902
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect</title>
<author><name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
</author>
<author><name sortKey="Watanabe, Oshi" sort="Watanabe, Oshi" uniqKey="Watanabe O" first="Oshi" last="Watanabe">Oshi Watanabe</name>
</author>
<author><name sortKey="Ohmiya, Suguru" sort="Ohmiya, Suguru" uniqKey="Ohmiya S" first="Suguru" last="Ohmiya">Suguru Ohmiya</name>
</author>
<author><name sortKey="Chiba, Fumiko" sort="Chiba, Fumiko" uniqKey="Chiba F" first="Fumiko" last="Chiba">Fumiko Chiba</name>
</author>
<author><name sortKey="Hayashi, Masahiro" sort="Hayashi, Masahiro" uniqKey="Hayashi M" first="Masahiro" last="Hayashi">Masahiro Hayashi</name>
</author>
<author><name sortKey="Suzuki, Tamio" sort="Suzuki, Tamio" uniqKey="Suzuki T" first="Tamio" last="Suzuki">Tamio Suzuki</name>
</author>
<author><name sortKey="Kawakami, Kazuyoshi" sort="Kawakami, Kazuyoshi" uniqKey="Kawakami K" first="Kazuyoshi" last="Kawakami">Kazuyoshi Kawakami</name>
</author>
<author><name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:15DEC7536283A6A703C82EC18C6C5BFC70F84F32</idno>
<date when="2016" year="2016">2016</date>
<idno type="doi">10.1111/1348-0421.12446</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-7QBR3RZ0-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000394</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000394</idno>
<idno type="wicri:Area/Istex/Curation">000374</idno>
<idno type="wicri:Area/Istex/Checkpoint">000007</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000007</idno>
<idno type="wicri:doubleKey">0385-5600:2016:Sato K:efficient:isolation:of</idno>
<idno type="wicri:Area/Main/Merge">000904</idno>
<idno type="wicri:Area/Main/Curation">000902</idno>
<idno type="wicri:Area/Main/Exploration">000902</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect</title>
<author><name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Miyagino‐ku, Sendai 983‐8520</wicri:regionArea>
<wicri:noRegion>Sendai 983‐8520</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
<wicri:noRegion>Aoba‐ku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Watanabe, Oshi" sort="Watanabe, Oshi" uniqKey="Watanabe O" first="Oshi" last="Watanabe">Oshi Watanabe</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
<wicri:noRegion>Miyagino‐ku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ohmiya, Suguru" sort="Ohmiya, Suguru" uniqKey="Ohmiya S" first="Suguru" last="Ohmiya">Suguru Ohmiya</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
<wicri:noRegion>Miyagino‐ku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chiba, Fumiko" sort="Chiba, Fumiko" uniqKey="Chiba F" first="Fumiko" last="Chiba">Fumiko Chiba</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
<wicri:noRegion>Miyagino‐ku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hayashi, Masahiro" sort="Hayashi, Masahiro" uniqKey="Hayashi M" first="Masahiro" last="Hayashi">Masahiro Hayashi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
<wicri:noRegion>2‐2‐2 Iida‐nishi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Suzuki, Tamio" sort="Suzuki, Tamio" uniqKey="Suzuki T" first="Tamio" last="Suzuki">Tamio Suzuki</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata 990‐9985, 2‐2‐2 Iida‐nishi</wicri:regionArea>
<wicri:noRegion>2‐2‐2 Iida‐nishi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kawakami, Kazuyoshi" sort="Kawakami, Kazuyoshi" uniqKey="Kawakami K" first="Kazuyoshi" last="Kawakami">Kazuyoshi Kawakami</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai 980‐8575, 2‐1 Seiryo‐machi, Aoba‐ku</wicri:regionArea>
<wicri:noRegion>Aoba‐ku</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<affiliation wicri:level="1"><country xml:lang="fr">Japon</country>
<wicri:regionArea>Virus Research Center, Clinical Research Division, Sendai Medical Center, 2‐8‐8 Miyagino, Sendai 983‐8520, Miyagino‐ku</wicri:regionArea>
<wicri:noRegion>Miyagino‐ku</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Japon</country>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Japon</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Microbiology and Immunology</title>
<title level="j" type="alt">MICROBIOLOGY AND IMMUNOLOGY</title>
<idno type="ISSN">0385-5600</idno>
<idno type="eISSN">1348-0421</idno>
<imprint><biblScope unit="vol">60</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="801">801</biblScope>
<biblScope unit="page" to="805">805</biblScope>
<biblScope unit="page-count">5</biblScope>
<date type="published" when="2016-11">2016-11</date>
</imprint>
<idno type="ISSN">0385-5600</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0385-5600</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Isolation of human parainfluenza virus (HPIV) serotypes 1 and 3 from clinical specimens is not very efficient because of the lack of a cell culture system capable of inducing CPE. In this study, the utility of a melanoma cell line, MNT‐1, that allows HPIV growth and displays CPE was demonstrated. In particularly, the efficiency of isolating HPIV1 and HPIV3 using MNT‐1 was greater than for cell lines conventionally used for HPIV isolation. Our demonstrated efficacy of HPIV1 and HPIV3 isolation with apparent CPE using the MNT‐1 cell culture system has the potential to improve virus isolation from clinical specimens.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
</noRegion>
<name sortKey="Chiba, Fumiko" sort="Chiba, Fumiko" uniqKey="Chiba F" first="Fumiko" last="Chiba">Fumiko Chiba</name>
<name sortKey="Hayashi, Masahiro" sort="Hayashi, Masahiro" uniqKey="Hayashi M" first="Masahiro" last="Hayashi">Masahiro Hayashi</name>
<name sortKey="Kawakami, Kazuyoshi" sort="Kawakami, Kazuyoshi" uniqKey="Kawakami K" first="Kazuyoshi" last="Kawakami">Kazuyoshi Kawakami</name>
<name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<name sortKey="Nishimura, Hidekazu" sort="Nishimura, Hidekazu" uniqKey="Nishimura H" first="Hidekazu" last="Nishimura">Hidekazu Nishimura</name>
<name sortKey="Ohmiya, Suguru" sort="Ohmiya, Suguru" uniqKey="Ohmiya S" first="Suguru" last="Ohmiya">Suguru Ohmiya</name>
<name sortKey="Sato, Ko" sort="Sato, Ko" uniqKey="Sato K" first="Ko" last="Sato">Ko Sato</name>
<name sortKey="Suzuki, Tamio" sort="Suzuki, Tamio" uniqKey="Suzuki T" first="Tamio" last="Suzuki">Tamio Suzuki</name>
<name sortKey="Watanabe, Oshi" sort="Watanabe, Oshi" uniqKey="Watanabe O" first="Oshi" last="Watanabe">Oshi Watanabe</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000902 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000902 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:15DEC7536283A6A703C82EC18C6C5BFC70F84F32 |texte= Efficient isolation of human parainfluenza viruses 1 and 3 using MNT‐1, a human malignant melanoma cell line system that exhibits an apparent cytopathic effect }}
This area was generated with Dilib version V0.6.33. |